StockData
Bioventus Inc. logo

Bioventus Inc. (BVS) stock

BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3042% below fair value
$10.46−0.20 (-1.88%)

Close on Nov 16, 2026Market cap $879.60MP/E 13.6Yield –

Bioventus market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Bioventus's market cap was $776.51M on Nov 11, 2026, against $510.18M a year earlier. Over the last 5 years it ranged from $62.00M to $951.98M, with a median of $443.70M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$776.51M+55.3%
2025Dec 31, 2025$500.10M-25.5%
2024Dec 31, 2024$671.48M+104.3%
2023Dec 29, 2023$328.62M+109.8%
2022Dec 30, 2022$156.65M–

More Bioventus figures

See a number that looks wrong?